Please try another search
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer’s disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.
Name | Age | Since | Title |
---|---|---|---|
Susan Catalano | 59 | 2007 | Member of Scientific Advisory Board |
Cynthia A. Lemere | - | - | Member of Scientific Advisory Board |
Harry LeVine | - | - | Member of Scientific Advisory Board |
Alison M. Goate | - | - | Member of Scientific Advisory Board |
Steven T. DeKosky | - | - | Member of Medical Advisory Board |
Jack A. Khattar | 63 | 2020 | Independent Chairman of the Board |
Robert H. Mach | - | - | Member of Scientific Advisory Board |
Tara L. Spires-Jones | - | - | Member of Scientific Advisory Board |
Aaron Glenn Louis Fletcher | 43 | 2015 | Independent Director |
Kaj Blennow | - | 2018 | Member of Medical Advisory Board |
Lisa Ricciardi | 64 | 2019 | CEO, President & Director |
Peggy Wallace | 67 | 2016 | Independent Director |
John Harrison | - | 2018 | Member of Medical Advisory Board |
Larry Ereshefsky | - | - | Member of Medical Advisory Board |
Brett P. Monia | 63 | 2020 | Independent Director |
Quang X. Pham | 59 | 2023 | Director |
Henrik Zetterberg | - | 2018 | Member of Medical Advisory Board |
Rolf Craven | - | - | Member of Scientific Advisory Board |
Philip Scheltens | - | - | Member of Medical Advisory Board |
Ellen B. Richstone | 72 | 2021 | Independent Director |
Mary Sano | - | - | Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review